Sale disclosed
George M. Milne Jr
Director
Common Stock
- Reported value
- $830.9K
- Reported price
- $27.6968 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Amylyx Pharmaceuticals, Inc.
Last 30 daysNo qualifying insider buying. Sales: $3.78M by 6 insiders.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Chief Medical Officer
Common Stock
$12,834 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Medical Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Co-Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Co-Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-1 | 30,000$27.70 / share | $830.9K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Medical Officer | Common StockSale2 trades | 10,028avg $32.40 / share | $324.87K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Chief Financial Officer | Common StockSale2 trades | 10,810avg $32.36 / share | $349.82K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Chief Legal Officer | Common StockSale2 trades | 9,536avg $32.46 / share | $309.51K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Co-Chief Executive Officer | Common StockSale2 trades | 30,464avg $32.18 / share | $980.26K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Co-Chief Executive Officer | Common StockSale2 trades | 30,464avg $32.19 / share | $980.5K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Director | Common StockOption exercise or conversion | 25,000$1.76 / share | $44K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 25,000$5.05 / share | $126.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units25,000$1.76 exercise / conversion price | Not a separate purchase | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units25,000$5.05 exercise / conversion price | Not a separate purchase | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Chief Financial Officer | Common StockGrant or award | 22,807Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Co-Chief Executive Officer | Common StockGrant or award | 60,039Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Legal Officer | Common StockGrant or award | 21,284Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Medical Officer | Common StockGrant or award | 22,807Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Co-Chief Executive Officer | Common StockGrant or award | 60,039Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
Showing the latest 20 of 28 trades. Show all 28 trades
This reflects the filings imported so far, not a complete trading history.